Humoral immune response after anti-SARS-CoV-2 vaccine “booster” dose in patients with monoclonal gammopathy of undetermined significance (MGUS)

Humoral immune response after anti-SARS-CoV-2 vaccine “booster” dose in patients with monoclonal gammopathy of undetermined significance (MGUS)

Not Applicable.

Saved in:

Bibliographic Details
Main Authors:	NICOLA SGHERZA, Paola Curci, Rita Rizzi, Angela Maria Vittoria Larocca, Luigi Vimercati, Silvio Tafuri, Maria Chironna, Pellegrino Musto
Format:	Article
Language:	English
Published:	PAGEPress Publications 2023-01-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	MGUS anti SARS-CoV-2 vaccine serological response
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/5188
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antibody response to breakthrough SARS-CoV-2 infection in “booster” vaccinated patients with multiple myeloma according to B/T/NK lymphocyte absolute counts and anti-CD38 treatments
by: NICOLA SGHERZA, et al.
Published: (2024-02-01)

IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA?
by: Ugo Testa, et al.
Published: (2024-04-01)

Monoclonal Gammopathy of Undetermined Significance (MGUS) in a Man with Fragile X-associated Tremor/Ataxia Syndrome
by: Tanjung A. Sumekar, et al.
Published: (2011-01-01)

Daratumumab-based treatment of monoclonal gammopathy–associated angioedema due to acquired C1-inhibitor deficiency
by: Remy S. Petersen, MD, et al.
Published: (2024-11-01)

Concomitant transformation to multiple myeloma and acute biphenotypic leukemia from MGUS simultaneously diagnosed with essential thrombocythemia 37-years before.
by: Pasquale Niscola
Published: (2014-08-01)

Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort
by: Eve Roman, et al.
Published: (2021-02-01)

Correction: Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort
Published: (2022-07-01)

Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China
by: Anping Xu, et al.
Published: (2024-12-01)

Monoclonal Gammopathy of Undetermined Significance Disguised as Chronic Neutrophilic Leukemia
by: Monique A Hartley-Brown, et al.
Published: (2010-02-01)

Monoclonal Gammopathy of Undetermined Significance Disguised as Chronic Neutrophilic Leukemia
by: Monique A Hartley-Brown, et al.
Published: (2010-02-01)

Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS)
by: Alessandra Trojani, et al.
Published: (2024-12-01)

IgA Monoclonal Gammopathy of Undetermined Significance and Complication of Streptococcus mitis Bacteremia
by: Jennifer Paterno, et al.
Published: (2020-01-01)

Trabecular Attenuation of L1 in Adult Patients with Multiple Myeloma: An Observational Study on Low-Dose CT Images
by: Carlo Augusto Mallio, et al.
Published: (2024-10-01)

Monoclonal gammopathy of undetermined significance with multiple paraproteins: A population‐based screening study
by: Sæmundur Rögnvaldsson, et al.
Published: (2024-11-01)

Genetically determined telomere length in monoclonal gammopathy of undetermined significance, multiple myeloma risk and outcome
by: Matteo Giaccherini, et al.
Published: (2024-11-01)

Illuminating the Shadows: Innovation in Advanced Imaging Techniques for Myeloma Precursor Conditions
by: Kara I. Cicero, et al.
Published: (2025-01-01)

Monoclonal Gammopathy of Undetermined Significance with Amyloid Deposition in the Lung and Non-Amyloid Eosinophilic Deposition in the Brain: A Case Report
by: Francois Abi-Fadel, et al.
Published: (2010-01-01)

Development of Renal Failure without Proteinuria in a Patient with Monoclonal Gammopathy of Undetermined Significance: An Unusual Presentation of AL Kappa Amyloidosis
by: Yijuan Sun, et al.
Published: (2012-01-01)

Serum B-cell maturation antigen could be a simple and accurate biomarker to identify and prognosticate monoclonal gammopathy of undetermined significance and smoldering multiple myeloma
by: Masanori Toho, et al.
Published: (2025-01-01)

Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role
by: Giovanni D’Arena, et al.
Published: (2016-01-01)

The significance of free light-chain ratio in light-chain monoclonal gammopathy of undetermined significance: a flow cytometry sub-study of the iStopMM screening study
by: Jón Þórir Óskarsson, et al.
Published: (2024-12-01)

Bortezomib maintenance for the treatment of Monoclonal Gammopathy of Renal Significance
by: Holly Lee, et al.
Published: (2019-01-01)

A case of ulcerated nodules in association with a monoclonal gammopathy
by: Sheena Bhadresha, MBBS, MRCP, et al.
Published: (2024-12-01)

EFFECTS OF DARATUMUMAB ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE PLANNED TO RECEIVE AUTOLOGOUS TRANSPLANTATION: WHAT’S THE RELEVANCE?
by: Pellegrino Musto, et al.
Published: (2024-08-01)

Two decades of occurrence of non-pathogenic rabbit lagoviruses in Italy and their genomic characterization
by: Patrizia Cavadini, et al.
Published: (2024-11-01)

Urine analysis in monoclonal gammopathies at diagnosis: settling cut-off values
by: Vidal-Pla Mònica, et al.
Published: (2024-09-01)

Diagnostic and Therapeutic Aspects of Monoclonal Gammopathies of Renal Significance (MGRS): An Update
by: Giuseppe Stefano Netti, et al.
Published: (2024-12-01)

Ocular Signs and Ocular Comorbidities in Monoclonal Gammopathy: Analysis of 80 Subjects
by: Kitti Kormányos, et al.
Published: (2021-01-01)

Acquired von Willebrand Disease Associated with Monoclonal Gammopathy of Unknown Significance
by: Sijan Basnet, et al.
Published: (2017-01-01)

Discordance between humoral and cellular immune responses to cytomegalovirus infection in CMV seropositive patients awaiting lung transplantation
by: Meritxell Boada-Pérez, et al.
Published: (2025-01-01)

Single monoclonal spike characterized as double monoclonal gammopathy in a patient with multiple myeloma: A rare finding
by: Rajni Saijpaul, et al.
Published: (2023-01-01)

Hepatitis B Associated Monoclonal Gammopathy That Resolved after Successful Liver Transplant
by: P. Sreenivasan, et al.
Published: (2009-01-01)

Monoclonal gammopathy of renal significance; experience of a tertiary care hospital in India
by: Shashank Mishra, et al.
Published: (2024-05-01)

Prospective, case-control study of serological response after two doses of BNT162b2 anti-SARS-CoV-2 mRNA vaccine in transfusion-dependent thalassemic patients
by: NICOLA SGHERZA, et al.
Published: (2022-06-01)

Two Cases of Heavy Chain MGUS
by: Jan Van Keer, et al.
Published: (2016-01-01)

Acquired von Willebrand Syndrome in IgM Monoclonal Gammopathy as the Presentation of Lymphoplasmacytic Lymphoma
by: Zachary Wolfe, et al.
Published: (2017-01-01)

Persistent Increase in Serum Alkaline Phosphatase in a Patient with Monoclonal Gammopathy of Undefined Significance
by: I. Ramasamy
Published: (2020-01-01)

Cellular and Humoral Response After Induction of Protection and After Finishing <i>Hymenoptera</i> Venom Immunotherapy
by: Ajda Demšar Luzar, et al.
Published: (2024-11-01)

Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain)
by: Ana C. Montagud, et al.
Published: (2025-01-01)

Hematologists/Physicians Need to Be Aware of Pseudohypercalcemia in Monoclonal Gammopathy: Lessons from a Case Report
by: Svenja F. B. J. Mennens, et al.
Published: (2024-01-01)